These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 9405681)
1. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Oliver PM; Fox JE; Kim R; Rockman HA; Kim HS; Reddick RL; Pandey KN; Milgram SL; Smithies O; Maeda N Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14730-5. PubMed ID: 9405681 [TBL] [Abstract][Full Text] [Related]
2. Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy. Vellaichamy E; Zhao D; Somanna N; Pandey KN Physiol Genomics; 2007 Oct; 31(2):193-202. PubMed ID: 17566078 [TBL] [Abstract][Full Text] [Related]
3. Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models. Pandey KN; Oliver PM; Maeda N; Smithies O Endocrinology; 1999 Nov; 140(11):5112-9. PubMed ID: 10537139 [TBL] [Abstract][Full Text] [Related]
8. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload. Patel JB; Valencik ML; Pritchett AM; Burnett JC; McDonald JA; Redfield MM Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H777-84. PubMed ID: 15778276 [TBL] [Abstract][Full Text] [Related]
9. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. Rubattu S; Bigatti G; Evangelista A; Lanzani C; Stanzione R; Zagato L; Manunta P; Marchitti S; Venturelli V; Bianchi G; Volpe M; Stella P J Am Coll Cardiol; 2006 Aug; 48(3):499-505. PubMed ID: 16875975 [TBL] [Abstract][Full Text] [Related]
10. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. Knowles JW; Esposito G; Mao L; Hagaman JR; Fox JE; Smithies O; Rockman HA; Maeda N J Clin Invest; 2001 Apr; 107(8):975-84. PubMed ID: 11306601 [TBL] [Abstract][Full Text] [Related]
11. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart. Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869 [TBL] [Abstract][Full Text] [Related]
12. The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms. Pandey KN FEBS J; 2011 Jun; 278(11):1792-807. PubMed ID: 21375691 [TBL] [Abstract][Full Text] [Related]
13. Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A-/-apolipoprotein E-/- mice. Alexander MR; Knowles JW; Nishikimi T; Maeda N Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1077-82. PubMed ID: 12702516 [TBL] [Abstract][Full Text] [Related]
14. Regulation of cardiac angiotensin-converting enzyme and angiotensin AT1 receptor gene expression in Npr1 gene-disrupted mice. Pandey KN; Vellaichamy E Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):e70-7. PubMed ID: 19843097 [TBL] [Abstract][Full Text] [Related]
15. Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A. Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Hamanaka I; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K Endocrinology; 2004 Feb; 145(2):951-8. PubMed ID: 14592959 [TBL] [Abstract][Full Text] [Related]
16. Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. Ellmers LJ; Scott NJ; Piuhola J; Maeda N; Smithies O; Frampton CM; Richards AM; Cameron VA J Mol Endocrinol; 2007 Feb; 38(1-2):245-57. PubMed ID: 17293444 [TBL] [Abstract][Full Text] [Related]
17. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene. Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452 [TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular significance of the natriuretic peptide receptor, guanylyl cyclase-A, from studies using genetically engineered mice]. Kishimoto I Nihon Rinsho; 2004 Sep; 62 Suppl 9():38-42. PubMed ID: 15506333 [No Abstract] [Full Text] [Related]
19. Deficiency of Cardiac Natriuretic Peptide Signaling Promotes Peripartum Cardiomyopathy-Like Remodeling in the Mouse Heart. Otani K; Tokudome T; Kamiya CA; Mao Y; Nishimura H; Hasegawa T; Arai Y; Kaneko M; Shioi G; Ishida J; Fukamizu A; Osaki T; Nagai-Okatani C; Minamino N; Ensho T; Hino J; Murata S; Takegami M; Nishimura K; Kishimoto I; Miyazato M; Harada-Shiba M; Yoshimatsu J; Nakao K; Ikeda T; Kangawa K Circulation; 2020 Feb; 141(7):571-588. PubMed ID: 31665900 [TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptides and cardiac hypertrophy. London B J Am Coll Cardiol; 2006 Aug; 48(3):506-7. PubMed ID: 16875976 [No Abstract] [Full Text] [Related] [Next] [New Search]